Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership under the School of Law and is dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. The CARB-X portfolio is the world's largest early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products to prevent, diagnose and treat life-threatening bacterial infections. CARB-X is grant-funded and currently supported by multiples government and foundation funders plus in-kind contributions. The CARB-X environment is innovative, dynamic, energetic, and rapidly evolving.
This job listing is no longer active.
Check the left side of the screen for similar opportunities.